Primary angioplasty for myocardial infarction improves long-term survival: PAMI-1 follow-up  by Nunn, Christopher et al.
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wa~ performed by using CAPS II system. As of August '95,175 lesions (70%) 
out of 250 screened lesions underwent successful dilatation by 1.5 mm 
balloons. Sixty lesions (34%) were randomized (vessel size ~ 2.5 mm and 
lesion length _< 30 mm by visual estimation) (Balloon (BA) group 30, ST group 
30). All procedures in the CS group were successful without any evidence 
of subacute steel thrombosis, Multiple Stans were used in 17 lesions (57%). 
In the BA group, 9 lesions (30%) requimcl bail-out CS due to delayed distal 
flow(2 lesions)and residual stenosis > 50% (7 lesions) (% diameter stenosis 
74 :l: 5.2% (67-81)). In additional 2 lesions (9%), CS was performed due to 
reocclusion at 24 hours study, 
ST (n = 30) BA (n = 30) P value 
Proximal RD (~'m) 3.14 ± 0.35 2.97 ~ 0.36 NS 
MLD (post) 2,29 :t: 0.47 1.87 ± 0.40 <0.001 
MLD (24 hi's) 2.23 ± 0.41 1.63 ± 0.64 <0.001 
MLD (3-6 M) 1.57 ± 0.60 1.60 -*- 0.72 NS 
Binary restenosls (%) 36 (9/25) 33 (8/24) NS 
TLR (%) 3-" (7/25) 29 (7/24) NS 
RD:  Reference diameter (ram), MLD: Minimal umen diameter (ram), TLR: Target lesion 
revascularizatioe. 
Thus, CS was effective in preventing eady reocolusion and associated with 
larger post and 24 hours MLD. This favorable acute luminal outcome over 
BA was not sustained at 3-6  months follow-up. BA supported by bail-out CS 
was equally effective as elective CS in the management of TO. 
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~ Coronary Staining Following Successful 
Angioplasty for Total Occlusions: Preliminary 
Results of a Randomlead Trial 
Martyn Thomas, Jane Hancock, Steve Holmberg, Ray W~nwright, 
David Jewitt, Oept of CardiG/ogy, King's College Hospital, UK 
The medium term results of balloon angioplasty for total coronary occlusions 
are ,oDor because of high reoccfusion [RO ! and restenosis [RSi rates. The 
angiographic (minimal luminal diameter [MLD], RO, RS and ejection fraction 
[El=l) and clinical (q~t PTCA, CABG and death) benefit of sleet deployment 
at the occlusion site is unknown. We have rendomised 60 patients to "no 
steel" (Gp A) or'sight" (Gp B) following successful PTCA of a total occlusion. 
Time of occlusion was similar in Gp A and Gp B (9 ± 10 v 14 ± 17 weeks 
respectively, NS). Post procedure angiographic results were significantly 
better in Gp B. 
EF Ret MLD % Stenosis 
Gp A (n = 30) 53.1% ~.5 mm 2.8 mm 19.1% 
Gp B (n = 30) 59.6 % 3.3 mm 3.3 mm - t .1% 
p value NS NS p < 0.01 p < 0.001 
There was no clinical in,patient vessel closure. Six month angiographic 
data is currently available in 40 patients. Coronary patency, residual % 
stenosis and EF is significantly belte, in Gp B. MLD is not statistically different 
in Gp A (1.5 ± 1.3 ram) and Gp B (2.0 ± 1.0 ram). 
EF RO RS % stenosis 
Gp A (n = 20) 58.0 % 6/20 6/20 60.0% 
Gp B (n = 20) 70.1% 1/20 4/20 37.8% 
p value p < 0.05 p < 0.05 NS p < 0.05 
Clinical events in the 2 groups is similar (mean follow up 37 weeks), 
Rpt PTGA CABG Death 
GP A (~ = 30) 4/30 2/30 1/30 
Gp B (n = 30) 2/30 1/30 0/30 
Six month results of this randomised study indicate a significant benefit in 
patency, residual % stenosis and left ventricular function if a stent is deployed 
at the site of occlusion following successful PTCA. 
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~The for Treating Calcilied Lesions Optimal Strategy 
in Large Vessels: Comparison of Intravascular 
Ultrasound Results of Rotational Atherectomy + 
Adjunctive PTCA, DCA, or Stems 
Gaston R. Dussaiiiant, Gary S. Mintz, Augusto D. Pichard, Kenneth 
M. Kent, Lowell F, Sailer, Jeffrey J, Popma, Carol Wa'-h, Paul Mackel, 
Jennifer Griffin, Kathy Morgan, Tammy Weaver, Martir, % Leon. Washi.'Pgton 
Hospital Center, Washington DC 
Treatment results of rotational athemctomy (RA) in calcified lesions in large 
(> 3 ram) vessals are frequently suboptimal. To determine the best adjuno- 
live device after RA, wo compared acute tntravascular ultrasound results 
(measurement of final lumen area and final diameter stenosis) following RA 
and adjunctive PTCA (N = 235), DCA (N = 120), or Palmaz-Schatz stents (N 
= 83) in lesions matched for reference lumen area and total and superficial 
lesion calcium (Ca): 
RA+ RA+ RA+ Anova 
PTCA DCA Stem p 
Reference lumen area (ram 2) 9.1 ~ 2.5 9.5 • 2.9 9.5 ± 3.0 0.3102 
Total arc of Ca (~) 200±113 201±63 212±105 0.6372 
Arc 0f superficial Ca ( a ) 175±119 175+108 159±120 0.6300 
Real lumen area (ram 2 ) 5.0±1.4 6.5 ~: 1.9 7.1 :E 2.0 <0.0001 
Final diarnetar stsnosia (%) 24±13 16±13 12±12 ~0.0001 
Final lumen area was 300 larger with RA + DCA and 42% larger with RA 
+ Stent than with RA + PTCA. Final DS was 33°/,= smaller with RA + DCA 
and 50°/, smaller with RA + Steel than with RA + PTCA. Furthermore, there 
were no procedural complications (including perforation), no subacute stent 
thrombosis, no major in-hospital complications, and only one 30 day clinical 
event (death due to noncardiae multisystam failure) after RA + Stsnt. We 
conclude: In > 3 mm vessels with calcified lesions, RA + Stent achieves the 
largest lumen and smallest DS (vs RA + PTCA or RA + DCA). Late fcllow-up 
will determine if the superior acute lumen dimensions after RA ÷ Stent result 
in fewer subsequent revascutarization events. 
PTCA in Acute Myocardial Infarction and the 
Influence of Gender on Outcome 
Tuesday, March 26, 1996, 10:30 a.m.-Noon 
Orange County Convention Center, Room 414B 
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[:Z'-43--'~ Determinants of 30 day and I Year Morlaiity in Acute 
Myocardial Infarction: Benefit of Early Angiography 
Conor F. Lundergan, Jonathan S. Reiner, Allan M. Ross. George 
Washington University, Washington, D.C. 
Independent clinical predictom of 30 day and I year mortality in acute my- 
ocardiat infarction (AMI) have been described previously and have shown 
expected (e.g., age) and unexpected (e.g., height} predictors of mortality. The 
GUSTO-1 Angiographic Tnal data base was used to determine the contn'bu- 
tion of clinical and angiographic variables to 30 day and one year mortality 
by logistic regression analysis in 1L:~O0 patients with 90 minute post treatment 
angiogrsphy. Variables considered to be related to mortality (age, gender, 
diabetes, time to treatment, history of hypertension or previous MI, body 
weight, infarct site, Killip class) were entered into the model in a step~se 
fashion and significance determined. Angiographic v,~riables included infarct 
related arlery (IRA) 90 minute TIMI (0.1 vs 2.3) flow grade, # of diseased 
vessels anti one week post AMI ejection fraction (EF). Independent deter- 
minants of 30 day and one year mortality were: (RR = relative risk; CI = 
contidance limit; NS = not signWc, ant) 
30 Day Mo,'laBty One Year Morlality 
RR 95% CI RR 95% Ct 
Age (< 78, _> 75) 3.8 (23, 6.7) 4.0 (2.5, 6.4) 
Female 2.5 (1.5, 4.2) NS 
Diabete,~ NS 1.7 (1.0, 2.9) 
Body Weight NS 0.97 (0.96, 0.98) 
Mul]ivessel CAD 1.9 (1.2,3.2) 2.0 (1_o.3.1) 
TIMI Flow 3.9 (2.4, 6.6) 2.6 (1.7, 4.2) 
EF (<_ 40, > 40) 3.0 (1.7, 5.5) 3.7 (2.2, 6.0) 
Conc/us/ons: 1. Angiographic variables add significant prognostic informa- 
tion to early and late mortality prediction in AMI beyond that provided by 
clinical variables alone. 2. These data suggest treatment strategies for AM1 
should incorporate determination of eady IRA patency to assess treatment 
efficacy and passsibly optimize Outcome. 3. Early IRA patency improves 
e,=ly and late survival independent of El:. 
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~-~ Primary for Myocardial Infarction Angioplasty 
ImprovPs Long-Term Survival: PAMI-1 Follow-up 
Christopher Nunn, William O'NeilL Donald Rothbaum, James O'Keefe, Jr., 
Paul Ovedie, Bryan Donohue, Denise Mason, Tom Catiin, Cindy Grines. 
William Beaumont Hospital, Royal Oak, MI 
Randomized ldals of PTCA vemus thrombolytic therapy for acute myocardial 
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infarction (MI) have demonstrated improved short-tsnn outcome for the PTCA 
patients, however few data exist regaiding long*term outcome. The PAMI-I 
trial rafldomized 395 patients within 12 hours of MI to repedusion with tPA or 
primary PTCA. The primazy endpaint was combined death or recurrent MI. 
In hospital, one month, six month, one and 2 year events were recorded by 
means of physician or nurse visits, questionnaire or telephone contact, with 
the following clinical events recorded: Non-pretecol PTCA, CABG, recurrent 
M,= er death. 
By 2 years, non-protocol PTCA or CABG was performed more commonly 
in tPA treated patients (56 vS 39%, p < 0.0012). When considered separately, 
death (9,5 vs 6.1%) or recurrent MI (14 vs 9,7=/=) was not significantly different 
between tPA and PTCA treated patients. However, 24 month survival without 
reinfarction tended to favor the PTCA group (85.6 va 79%, p = 0.07). 
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Thus, primary PTCA of AMI is associated with reduced need for non- 
protocol revaeculadzatisn and favorable vent-free survival OVer 2 years. 
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~ L a c k  Long Prognostic Signiticence of  Term of 
Infarct-Related Artery Patency at Late (> 1 Month) 
Anglogrephy Alter Acute Myocardial Infarction in 
Medically*Treated Patients. An Incentive for  Early 
Recanalization Alter Myocardial Infarction 
Romaln Cador, MD, Nicolas Danchin, MD, Michael AngloL (~;ivier Dibon, 
Christine Seiton-Suty, Yves Juilll~re, Etienne Allot, Free(isis Cherder. CHU 
Nancy-Brebois, France 
Recent data from the SAVE trial suggest hat infarst-mlated artery (IRA) pa- 
fancy assessed in the first days after myocardial infarction (AMI} has irp~odant 
prognostic significance. To assess the very long term (15 years) prognostic 
significance of IRA patancy determined late (> 1 month) after MI, we ana- 
lyzed the 15-year follow-up of 142 consecutive pts who undenNent coronary 
angiography 2.9 :~ 1.3 months after AMI (range 1--6 months) in the year 1980 
and were treated medically in the first 6 months following anglography. 
Baseline parameters: age 47 4- 9 yrs, 91% men, anterior MI: 44%, preced- 
ing angina: 31%, residual angina: 35%, 1-vessel disease 45%, patent IRA 
(TIMI grade 3): 35%, LVEF 52 4-12%. 
Resu#s: By Cox multivariate analysis, the only independent predictorS of 
cardiac survival were LV endiastslic volume (EDV) (p < 0.01) and LVEF 
(p = 0.05), while IRA Patency had no prognostic significance (p = 0.65). 
In the subset of patients with single-vessel disease (n = 62) IRA patsncy 
was related to long term follow-up by univariate analysis (p < 0.05); after 
multivariate analysis, however, only LVEF was related to long term outcome. 
Thus our study fails to demonstrate a prognostic signifiCance for infamt- 
related artery patency de~ermined more than one month after AMI. These 
results suggest that recanalization of an secluded IRA should be performed 
sufficiently early after the acute episode to achieve beneficial clinical effects. 
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~ Primary PTCA Results In Similar In.Hcepital 
Outcomes In Females and Males Presenting With 
Acute Mt 
John Gdffin, William O'Neill, Brace Bredie, Shemj Theodosiou, Denise 
E. Jones, D~'ora Sachs, C, Constantini, C. Bales~ni, Gregg Stone. 
Cindy Grlnes. Virginia Beach Gee Hospital, Vi~jinia Beach, VA 
Thrombe~ic studies have demonstrated that females have an increased risk 
of intracrasial bleeding ~.nd eath compared to males. Few data, exist regard- 
ing gender differences when a mechanical repertusion strategy is utilized. 
We examined the clinical and anglogrephic characteristics of the 810 males 
and 290 females in the Primary Angioplasty In Myocardial Infarction II study 
to determine whether females had hlgl~r in.hespifal mortality and morbidity 
compared to males. Them were no differences between females and males 
in relation to incidence of antedor MI, HTN, prior CABG, prior MI, smoking 
or extent of CAD. Females were older (63.9 vs 58.8%, p ,= 0.0OOt), had a 
higher incidence of diabetes mellitus (2t vs 13%, p = 0.005), and were less 
likely to be thrembolytic eligible (62 vs 72%, p = 0,001). 
Despite these baseline differences, in.hospital outcomes were similar be- 
tween the two groups as follows: 
Mates Females P Value 
Successful PTCA 95% 97% 0.27 
Death 3% 3% 0.45 
Reinfarclion 4% 5% 0.72 
Reocclusion 5% 6% 0.42 
USA/Rec~th 14% 18% 0.14 
CHF 8% 10% 0.27 
CVA 0.9% 1% 0.49 
CABG 5.5% 6.6°/. 0.31 
VT or VF 11% 11% 0.85 
Thus, avoiding thrembolytic therapy aml performing primary PTCA ~:r AMI 
allows females high rates of reperfusion, low rates of stroke and a prognosis 
similar to mates. 
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~ 3.073 Danish Citizen With Acute Myocardial 
Infarction Showed No Sex Related Difference in 
Short end Long Term Prognosis  
Saran Galatius-Jensen, Jeppa Launbjerg and the DAVIT Study Group. 
Rigshospitalet, National University Hospital, Copenhagen, DK-Denmark 
Background: "[he prevailing view regarding prognosis after acute myocardial 
infarction is that females fare worse than males. 
Purpose: The purpose of the present study is to deecdbe in hospital (15 
days) and ten year prognosis after AM! in the two sexes in different age 
groups, 
Methods: 3,0'/3 patients with AMI from 16 coronary care units coVedng 
a fifth of the total Danish population were registered from June 1, 1979 to 
August 15, 1981. Deaths were recorded October 1, 1990 at the National 
Person Registration Office: cause of death was recorded from the death 
certificate and admission with recurrent infamtion at the Central County 
Patient Regisw. Mortality was separated into in hospital (15-days) and after 
disch~'ge (day 15 to 10-year). The patients were separated into three age 
groups (< 50 yearn, 50-65 years and > 65 years). 
ResultS: 24% females and 76% males were registered at index admission. 
The ratio females/males with age < 50 years was 1:5.9, with age 50-65 
years was 1:4.4 and with age > 65 years 1:2,0. Median age for fancies was 
66 years, for males 61 yearS. 
Age: < 50 years 50-.65 years > 65 years 
Gender:  Females/maYas Females/males Female.~rnaYes 
Mortality 13%/9% 17=/#12% 15~ 
before day 15 NS N~; NS 
Mortality P-2~35% 52'Y#53% 73%/7(P/, 
afJer day 15 NS NS NG 
Rsinfatction 45%/50% 50=/#61% 57%/63% 
after day 15 NS P = 0.02 NS 
Mortality af ter  60'Y~55% 7PM65% 88%/86% 
reinfarction NS N~ NS 
No differences in causes o1 de:~th was found between the genderS. 
Conclusion: No sex related difference exists regarding short and long term 
mortality after AMI. 
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~ Influence of  Gender on Short  end Long Term 
Survival After Acute Myocordlal  Infarction 
Christian Torp-Pedersen, Lars K~eber, Michael Ottessn, Hans Burchart, 
Eva Kerup, Kjeld Lyngbo~ for the TRACE Study Group. Gentoite U, iversity 
Hospital, Col~nhagen, Denmark 
A number of studies have shown an increased risk associated with female 
gender to,owing an acute myocardial infarction (MI). 
The TRACE (Trando|apri! Cardiac Evaluation) Register includes 6676 con. 
secutive patients with an enzyme confirmed acute myocardial infarction (MI) 
screened for entry into the TRACE trial. Medical history and complications of 
MI were obtained for all patients. Left ventricutsr systolic function was deter- 
mined by echocardiog,-aphy in a core laboratory as wall motion index (WMI) 
within 6 days of the infarction. Survival data were available for all except 5 
patients after 2--3 years. Thirty three % of patients were female, Females less 
often received thmmbolytic therapy than males (34%/44% (female/male)), 
more often had congestive heart failure (60%/50%), more often had diabetes 
(14%/9%). more often hypertension (28%/20%). and were older (mean age 
72 years/67 years). Thirty day survival was lower for females than for males 
(84 ..i- 2°/=/89 4- 1%, ±, 95% CI), At 1 year the difference had increased to 
72 ~ 2%/79 -4- 1% and at 3 years to 59 ± 2%/67 :E 1%. This difference 
